Symptomatic bone marrow metastases in breast cancer: A retrospective cohort study

OBJECTIVE: Breast cancer symptomatic bone marrow metastasis (BMM) is rare and has a poor prognosis. Chemotherapy is usually the primary treatment, but it has limited efficacy, resulting in dose reduction and a decrease in quality of life due to the adverse effects of the agent. Other than chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ruohan, Jia, Lin, Lu, Guanyu, Lv, Zheng, Cui, Jiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808780/
https://www.ncbi.nlm.nih.gov/pubmed/36605432
http://dx.doi.org/10.3389/fonc.2022.1042773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808780/
https://www.ncbi.nlm.nih.gov/pubmed/36605432
http://dx.doi.org/10.3389/fonc.2022.1042773

Ejemplares similares